<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Orchard Surgery</h1>
        This is some intro text. Please fill in our feedback <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=%20">survey</a>.

        <h2>Prescribing where Orchard Surgery is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0501021G0&amp;denomIds=5.1.2&amp;selectedTab=summary">Ceftriaxone sodium</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>4</td>
      <td>Cephalosporins</td>
      <td>76</td>
      <td>0.05</td>
      <td>0.00</td>
      <td>0.01</td>
      <td>6.77</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0501021G0AAADAD&amp;denomIds=5.1.2&amp;selectedTab=summary" target="_blank">Ceftriaxone 2g powder for solution for injection vials : 4</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1108010H0&amp;denomIds=11.8.1&amp;selectedTab=summary">Hyetellose</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>7</td>
      <td>Tear deficiency, eye lubricant/astringent</td>
      <td>78</td>
      <td>0.09</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>5.77</td>
      <td><img class="zoom" src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAPwAAABICAYAAADS8JgEAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAFTElEQVR4nO3dXYgVZRzH8e+TiVmRieUSGU5IhnUTFJW9aJfRGEgQJUIGhXXZGzWVF110MRVBWihY2QsUQRcFNUSBCIYFXURhZWTiREK0QZqaaL78u5hZOm17ds/L8zznbPP7wMOOztnnNwv7mzM7Z+YcZ2aISDOcNugNEJF4VHiRBlHhRRpEhRdpEBVepEFUeJEGUeFFGkSFF2kQFV6kQVR4kQZR4SUu53Qt9wD1XfgkK55NsmKRj40RkbB8PMM/BNznYR4RCcxH4bcAdyRZMdPDXCISkI/CvwR8BqzwMJeIBOSj8DuBV4B7PMwlIgH1XfgyTw3YBlyaZMWF/W+SiITi5WW5Mk9PAW8Ad/uYT0TC8Pk6/OvAmiQr9Nq+yJDyVs4yT/cBu4GbfM0pIn75fjZ+E7jT85wi4onvwm8DbvQ8p4h44rXwZZ6OAiRZMd/nvCLiR4gTbJ+iZ3mRoRSq8MsCzCsifQpR+O3oGV5kKHkvfJmnPwFzk6yY43tuEelPqItkdgDXB5pbRHoUqvA6rBcZQqEKrxN3IkMoVOG/BxYmWTE70Pwi0oMgha9vmf0CuCbE/CLSm5B3tm1Hh/UiQyV04XXiTmSIhCz818DiJCtGAmaISBeCFb7M05PARuDhUBki0p3Q706zkeotrM8PnCMiHQha+DJPDwGbgQdD5ohIZ2K8/9yLwOokK+ZFyBKRSQQvfJmnB4FXgQdCZ4nI5GK9w+wG4K4kK86LlCciE3BmcT69N8mKe4F1wHpgU5mnR6MEy3BxzjBzg96MpopWeIAkKy4AngBuAV4GvgJ2AT/XH2Yh/3cq/EBFLfyYJCsSYBWwBLgMWADsoyr/LuC7+uueMk9PRN9ACUeFH6iBFH68+tNqFvDPDmBJPRYB+4G9LaMcWy7z9MAgtlf6oMIP1FAUvp0kKxwwD7i4ZSQty3OAw8BoPX5tWf4dODjRKPP0WMyfQ1qo8AM11IXvRJIVZwEjwPx6jNTjXOCcNmNW/e1HaLNTmGAcBo7W41jLcus4Xt8aLO2o8AM17Qvfq/roYTbtdwrjx9lUO4ozxo1Z45bHGNWOoXXn8BdwAjhZfz3Rwb/HrztVD5tiear13Ty23f9N5T+PKZ9Z8UHy2Ie3TvaYTubpcv2wPcZXDgBlnm7t9LGYWV8DWNvvHNM1X9nKnm7ZPi68Wethjumar2xlT6tsfZa7SIOo8CIN4qPwmz3MMV3zla3saZXd2LP0Ik2kQ3qRBjm9mwc755YB1wGjZrbFOXcb1eWvPwLfAquB/Wb2gu8NnSL7QL3ukJltiJltZu8551YBC80sj5kNfE519naPmb0VOfs3YDkw18weiZC9ErjZzO4fv853dgf5K4ErgB/M7O2Y2fX6x4G9ZvZOt3N3+wy/tP6lHnuPukvM7DlgMZACT/Pvi098apttZtuAnOoy3KjZzrnLgV8C5U6aDdwO/EF1IUzs7GNUVzYeiZFtZu9T3Ucx0XZFza+Xnwcuip3tnFsO7Ox14m4LP/4P/pgnAKbKfpTqltvY2Uup9vahPi13suyZwEdUNxrFzl4MPAkcj5Td6brg+c65GVS/b5tiZwNXAlfT4+9bVyft6kONpVQ3pnwJLKQ6xNtNdTvrKqpD+vW9bEwf2SPAVcAnZvZuzOx674tzLgt4SN/u5/4GWAOcNLOnImf/CdwAzDCzdRGyz6QqWQ7MqNeNmtlrvrM7yE+p/hzeamYfx8w2sx3OuQS4tpdDep2lF2kQnaUXaRAVXqRBVHiRBlHhRRpEhRdpEBVepEFUeJEGUeFFGkSFF2kQFV6kQVR4kQb5G58xC/gCQrlmAAAAAElFTkSuQmCC"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1108010H0BBAAAA&amp;denomIds=11.8.1&amp;selectedTab=summary" target="_blank">Minims artificial tears 0.44% eye drops 0.5ml unit dose : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1304000N0&amp;denomIds=13.4&amp;selectedTab=summary">Fluocinolone acetonide</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>30</td>
      <td>Topical corticosteroids</td>
      <td>503</td>
      <td>0.06</td>
      <td>0.01</td>
      <td>0.01</td>
      <td>5.59</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1304000N0BBAIBD&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Synalar 0.025% gel : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1304000N0AAABAB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Fluocinolone acetonide 0.025% cream : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1304000N0AACACA&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Fluocinolone acetonide 0.025% / Clioquinol 3% cream : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1304000N0BBAAAB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Synalar 0.025% cream : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1304000N0BBAMCC&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Synalar C ointment : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1304000N0BBAHBC&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Synalar 1 in 4 Dilution 0.00625% ointment : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1304000N0AABBBB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Fluocinolone acetonide 0.025% ointment : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1304000N0AABCBC&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Fluocinolone acetonide 0.00625% ointment : 5</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1304000N0BBAGBB&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Synalar 0.025% ointment : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0206020F0&amp;denomIds=2.6.2&amp;selectedTab=summary">Felodipine</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>811</td>
      <td>Calcium-channel blockers</td>
      <td>1598</td>
      <td>0.51</td>
      <td>0.08</td>
      <td>0.08</td>
      <td>5.08</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0206020F0AAABAB&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Felodipine 5mg modified-release tablets : 97</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0206020F0AAADAD&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Felodipine 2.5mg modified-release tablets : 133</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0206020F0BKAAAB&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Cardioplen XL 5mg tablets : 264</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0206020F0BKABAC&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Cardioplen XL 10mg tablets : 136</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0206020F0BKACAD&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Cardioplen XL 2.5mg tablets : 155</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0206020F0AAACAC&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Felodipine 10mg modified-release tablets : 26</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1001010AH&amp;denomIds=10.1.1&amp;selectedTab=summary">Celecoxib</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>111</td>
      <td>Non-steroidal anti-inflammatory drugs</td>
      <td>527</td>
      <td>0.21</td>
      <td>0.03</td>
      <td>0.04</td>
      <td>4.98</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1001010AHAAAAAA&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Celecoxib 100mg capsules : 46</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1001010AHAAABAB&amp;denomIds=10.1.1&amp;selectedTab=summary" target="_blank">Celecoxib 200mg capsules : 65</a></div></td></tr></tbody></table>

        <h2>Prescribing where Orchard Surgery is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0206020A0&amp;denomIds=2.6.2&amp;selectedTab=summary">Amlodipine</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>592</td>
      <td>Calcium-channel blockers</td>
      <td>1598</td>
      <td>0.37</td>
      <td>0.75</td>
      <td>0.11</td>
      <td>-3.39</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0206020A0AAAAAA&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Amlodipine 5mg tablets : 343</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0206020A0AAABAB&amp;denomIds=2.6.2&amp;selectedTab=summary" target="_blank">Amlodipine 10mg tablets : 249</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000&amp;denomIds=13.2.1&amp;selectedTab=summary">Other emollient preparations</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>215</td>
      <td>Emollients</td>
      <td>309</td>
      <td>0.70</td>
      <td>0.89</td>
      <td>0.07</td>
      <td>-2.76</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000BBICBW&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Dermol 500 lotion : 97</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000BBJGCA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase gel : 48</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000BBAEA3&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Diprobase ointment : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000BBLDA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno moisturising creamy oil : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000BBAHAV&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Ultrabase cream : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000BBJMCB&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno lotion : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000BBLACA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase Dayleve gel : 8</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000BBMFCA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Doublebase emollient shower gel : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000BBCJA8&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aveeno cream : 16</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000AAA6A6&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">White soft paraffin 50% / Liquid paraffin 50% ointment : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000AACACA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Isopropyl myristate 15% / Liquid paraffin 15% gel : 6</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000BBKFA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Dermol cream : 15</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=130201000BBBAAL&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">E45 cream : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0802010G0&amp;denomIds=8.2.1&amp;selectedTab=summary">Azathioprine</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>9</td>
      <td>Antiproliferative immunosuppressants</td>
      <td>28</td>
      <td>0.32</td>
      <td>0.80</td>
      <td>0.19</td>
      <td>-2.60</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0802010G0AAAEAE&amp;denomIds=8.2.1&amp;selectedTab=summary" target="_blank">Azathioprine 50mg tablets : 9</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0106020M0&amp;denomIds=1.6.2&amp;selectedTab=summary">Senna</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>102</td>
      <td>Stimulant laxatives</td>
      <td>448</td>
      <td>0.23</td>
      <td>0.55</td>
      <td>0.14</td>
      <td>-2.34</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0106020M0AAACAC&amp;denomIds=1.6.2&amp;selectedTab=summary" target="_blank">Senna 7.5mg tablets : 96</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=0106020M0AAATAT&amp;denomIds=1.6.2&amp;selectedTab=summary" target="_blank">Senna 7.5mg/5ml oral solution sugar free : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1310012F0&amp;denomIds=13.10.1&amp;selectedTab=summary">Fusidic acid</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>26</td>
      <td>Antibacterial preparations also used systemically</td>
      <td>71</td>
      <td>0.37</td>
      <td>0.72</td>
      <td>0.15</td>
      <td>-2.33</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1310012F0BBAAAB&amp;denomIds=13.10.1&amp;selectedTab=summary" target="_blank">Fucidin 20mg/g cream : 1</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=N85047&amp;numIds=1310012F0AAABAB&amp;denomIds=13.10.1&amp;selectedTab=summary" target="_blank">Fusidic acid 2% cream : 25</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>